Stay updated with breaking news from Len Liptak. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As CPAP adherence challenges and device shortages persist, sleep specialists turn to endotyping and alternative therapies, like oral appliances, to personalize OSA care.
Research to be presented at SLEEP 2024 indicates ProSomnus' oral appliances improve OSA treatment outcomes and patient satisfaction.
ProSomnus Inc reported a 28% revenue increase for Q1 2024, totaling $7.5 million, despite undergoing Chapter 11 restructuring.
ProSomnus Records 28% Year-Over-Year Revenue Growth Accompanied by Continued Strong Customer SatisfactionPLEASANTON, Calif., May 16, 2024 -- ProSomnus, Inc. , the leading non-CPAP Obstructive Sleep...
ProSomnus, Inc. , the leading non-CPAP Obstructive Sleep Apnea therapy, today announced results for the first quarter ended March 31, 2024. ● ...